🇪🇺 Neorecormon in European Union

EMA authorised Neorecormon on 16 July 1997

Marketing authorisation

EMA — authorised 16 July 1997

  • Marketing authorisation holder: Roche Registration Limited
  • Status: approved

Neorecormon in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Other Oncology approved in European Union

Frequently asked questions

Is Neorecormon approved in European Union?

Yes. EMA authorised it on 16 July 1997.

Who is the marketing authorisation holder for Neorecormon in European Union?

Roche Registration Limited holds the EU marketing authorisation.